Nalaganje...
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
Quadrivalent human papillomavirus (4vHPV) vaccine was licensed for use in the United States in 2006 and through 2015 was the predominate HPV vaccine used. With the exception of syncope, a known preventable adverse event after any injected vaccination, both pre-licensure and post-licensure 4vHPV safe...
Shranjeno v:
| izdano v: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4964727/ https://ncbi.nlm.nih.gov/pubmed/27029786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1168952 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|